Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
GLP-1s are not recommended for people with medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease
If you want to cheat once in a while, it's not the end of the world, but I'll try not to do that, but it's not end of the world
It is also approved for adolescents aged 12 and older with obesity, with specific dosing protocols
Administration via intramuscular (IM) injection
Retatrutide is an investigational triple agonist that simultaneously activates three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
[Updated 2024 Jan 26]
US$ 20.16
US$ 20.74
/assets/production/practices/728823589dde9ee26538014746af0608984170b3/images/2742608.jpg)
US$ 25.45
US$ 29.55
US$ 25.04
US$ 25.05
US$ 29.31
US$ 28.15
